CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: molibresib
Accession: CHEBI:95082
browse the term
Definition: A member of the class of triazolobenzodiazepine that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine substituted by methyl, 2-(ethylamino)-2-oxoethyl, 4-chlorophenyl, and methoxy groups at positions 1, 4S, 6, and 8, respectively. It is an orally bioavailable inhibitor of BET family of proteins that has demonstrated antitumour activity in preclinical models of solid and hematologic malignancies.
Synonyms: exact_synonym: 2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-ethylacetamide
related_synonym: Formula=C22H22ClN5O2; GSK-525762A; GSK525762; GSK525762A; I-BET 762; I-BET762; InChI=1S/C22H22ClN5O2/c1-4-24-20(29)12-18-22-27-26-13(2)28(22)19-10-9-16(30-3)11-17(19)21(25-18)14-5-7-15(23)8-6-14/h5-11,18H,4,12H2,1-3H3,(H,24,29)/t18-/m0/s1; InChIKey=AAAQFGUYHFJNHI-SFHVURJKSA-N; SMILES=CCNC(=O)C[C@@H]1N=C(C2=CC=C(Cl)C=C2)C2=C(C=CC(OC)=C2)N2C(C)=NN=C12; molibresibum
xref: CAS:1260907-17-2; DrugBank:DB16239; HMDB:HMDB0244491; KEGG:D11326; LINCS:LSM-6334
xref_mesh: MESH:C554645
xref: PDBeChem:EAM; PMID:21068722; PMID:21568322; PMID:24015967; PMID:24107192; PMID:24335499; PMID:24985178; PMID:25338565; PMID:26304078; PMID:26367539; PMID:28024472; PMID:28254412; PMID:28648518; PMID:29246957; PMID:29476043; PMID:29777912; PMID:29802402; PMID:29928885; PMID:32328561; PMID:32820548; PMID:33339368; PMID:33876939; PMID:33907583; PMID:33955700; PMID:34648693; PMID:34724226; PMID:35175516; PMID:35357834; PMID:35758684; PMID:36139416; PMID:36350312; PMID:36834533; PMID:37992310; PMID:38017059; PMID:38565708; PMID:38669046
G
Apc
APC regulator of WNT signaling pathway
decreases response to substance
ISO
APC mutant form results in decreased susceptibility to molibresib
CTD
PMID:26367796
NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696
G
Apoa1
apolipoprotein A1
increases expression
ISO
molibresib results in increased expression of APOA1 mRNA; molibresib results in increased expression of APOA1 protein
CTD
PMID:21568322
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
G
Car9
carbonic anhydrase 9
decreases expression multiple interactions
ISO
molibresib results in decreased expression of CA9 mRNA molibresib inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]
CTD
PMID:27292261
NCBI chr 5:57,763,234...57,769,838
Ensembl chr 5:57,763,206...57,769,838
G
Casp3
caspase 3
increases activity
ISO
molibresib results in increased activity of CASP3 protein
CTD
PMID:26911376
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
increases activity
ISO
molibresib results in increased activity of CASP7 protein
CTD
PMID:26911376
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Ccnd1
cyclin D1
decreases expression
ISO
molibresib results in decreased expression of CCND1 mRNA
CTD
PMID:24874954
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Dkk1
dickkopf WNT signaling pathway inhibitor 1
multiple interactions
ISO
DKK1 protein inhibits the reaction [KMT2A protein results in decreased susceptibility to molibresib]
CTD
PMID:26367796
NCBI chr 1:228,381,521...228,385,202
Ensembl chr 1:228,381,521...228,385,202
G
Epas1
endothelial PAS domain protein 1
increases expression multiple interactions
ISO
molibresib results in increased expression of EPAS1 mRNA [Oxygen deficiency co-treated with molibresib] results in increased expression of EPAS1 mRNA
CTD
PMID:27292261
NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
G
Esr1
estrogen receptor 1
decreases expression
ISO
molibresib results in decreased expression of ESR1 mRNA
CTD
PMID:24874954
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Greb1
growth regulating estrogen receptor binding 1
decreases expression
ISO
molibresib results in decreased expression of GREB1 mRNA
CTD
PMID:24874954
NCBI chr 6:39,440,522...39,562,364
Ensembl chr 6:39,440,504...39,581,633
G
Ifng
interferon gamma
multiple interactions
ISO
molibresib inhibits the reaction [IL15 protein results in increased expression of IFNG protein]
CTD
PMID:29301935
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il15
interleukin 15
multiple interactions
ISO
molibresib inhibits the reaction [IL15 protein results in increased expression of IFNG protein]
CTD
PMID:29301935
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
G
Kmt2a
lysine methyltransferase 2A
multiple interactions decreases response to substance
ISO
DKK1 protein inhibits the reaction [KMT2A protein results in decreased susceptibility to molibresib]; pyrvinium inhibits the reaction [KMT2A protein results in decreased susceptibility to molibresib]
CTD
PMID:26367796
NCBI chr 8:45,116,763...45,193,320
Ensembl chr 8:45,118,814...45,193,181
G
Lox
lysyl oxidase
multiple interactions decreases expression
ISO
molibresib inhibits the reaction [Oxygen deficiency results in increased expression of LOX mRNA] molibresib results in decreased expression of LOX mRNA
CTD
PMID:27292261
NCBI chr18:45,964,544...45,977,431
Ensembl chr18:45,967,343...46,041,477
G
Myc
MYC proto-oncogene, bHLH transcription factor
multiple interactions
ISO
molibresib inhibits the reaction [Oxygen deficiency results in increased expression of MYC mRNA]
CTD
PMID:27292261
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Pfkfb3
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
increases expression multiple interactions
ISO
molibresib results in increased expression of PFKFB3 mRNA molibresib promotes the reaction [Oxygen deficiency results in increased expression of PFKFB3 mRNA]
CTD
PMID:27292261
NCBI chr17:66,983,629...67,064,702
Ensembl chr17:66,983,686...67,063,125
G
Tff1
trefoil factor 1
decreases expression
ISO
molibresib results in decreased expression of TFF1 mRNA
CTD
PMID:24874954
NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597
G
Tmem45a
transmembrane protein 45A
multiple interactions
ISO
molibresib inhibits the reaction [Oxygen deficiency results in increased expression of TMEM45A mRNA]
CTD
PMID:27292261
NCBI chr11:43,713,309...43,799,526
Ensembl chr11:43,713,782...43,799,526
G
Vegfa
vascular endothelial growth factor A
decreases expression multiple interactions
ISO
molibresib results in decreased expression of VEGFA mRNA molibresib inhibits the reaction [Oxygen deficiency results in increased expression of VEGFA mRNA]
CTD
PMID:27292261
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all